Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited (HKSE: 1177) is trading at HK$5.57, about ₹68 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 0.36% today. Indian residents can buy Sino Biopharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$5.49
Today's high
HK$5.69
52 week low
HK$4.19
52 week high
HK$8.54
1177 opened at HK$5.69, closed previously at HK$5.59, and has traded between HK$4.19 and HK$8.54 over the past 52 weeks.
About
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, benmelstobart injection under Andewei brand, unecritinib fumarate capsules under Anboni brand, envonalkib citrate capsule under Anluoqing brand, garsorasib tablets under Anfangning brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, trastuzumab for injection under Saituo brand, and pertuzumab injection, under Paletan brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand, and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji. In addition, the company develops liver disease drugs, such as Lanifibranor and TQA2225; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide, TRD205, an AT2R inhibitor, and TRD303, a ropivacaine sustained-release solution. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Key statistics
Avg. volume
95.40M
Market cap
HK$99.23B
P/E Ratio
35.78
Price-to-sales ratio
2.52
Enterprise value
CN¥87.07B
Free cash flow yield
6.09%
Debt-to-equity ratio
0.53
Return on equity
7.56%
ROIC
12.03%
Beta
0.63
Dividend yield
2.15%
Last dividend
HK$0.10
Financial overview
Revenue
CN¥31.83B
Earnings per share
CN¥0.13
Free cash flow
CN¥7.59B
Net profit margin
7.09%
Gross margin
82.43%
EBITDA
CN¥7.26B
Revenue growth
10.28%
Similar securities
This is not an investment recommendation
How to buy Sino Biopharmaceutical from India
Indian residents can buy Sino Biopharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Sino Biopharmaceutical and place an order
Find Sino Biopharmaceutical by name or by its ticker, 1177, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Sino Biopharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Sino Biopharmaceutical position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Sino Biopharmaceutical from India
Trading and taxes when buying Sino Biopharmaceutical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Sino Biopharmaceutical’s current yield is 2.15%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Sino Biopharmaceutical stock?
Yes. Sino Biopharmaceutical (1177) has been listed on the Hong Kong Stock Exchange since 2004, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Sino Biopharmaceutical share cost in rupees?
One Sino Biopharmaceutical share is HK$5.57 — about ₹68 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Sino Biopharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Sino Biopharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Sino Biopharmaceutical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Sino Biopharmaceutical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Sino Biopharmaceutical price. Paasa issues a capital-gains statement for your return.
Does Sino Biopharmaceutical pay a dividend, and how is it taxed in India?
Yes. Sino Biopharmaceutical pays a dividend and the current yield is 2.15%; the last declared dividend was HK$0.10 per share, about ₹1.22. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Sino Biopharmaceutical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Sino Biopharmaceutical shares held from India?
Hong Kong has no estate duty.
Do I have to declare Sino Biopharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Sino Biopharmaceutical holding, its cost and its closing value.
How do I sell Sino Biopharmaceutical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.